New treatment for advanced metastatic prostate cancer - Lutetium 177 PSMA therapy - London Business News | Londonlovesbusiness.comLutetium 177 PSMA Therapy offers promising new hope for patients with advanced metastatic prostate cancer by providing a targeted treatment approach.